This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024 at 12:01 PM EDT
While Novo Nordisk and Eli Lilly have soared in the past year, Roundhill Investments sees bigger gains ahead for the GLP-1 drugmakers.
